Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: Results from the German Conn's Registry

Clinical Endocrinology

Volumn 76, Issue 4, 2012, Pages 473-477

  Fischer, Evelyn ^a   Beuschlein, Felix ^a   Degenhart, Christoph ^a   Jung, Philip ^a   Bidlingmaier, Martin ^a   Reincke, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; RENIN; SPIRONOLACTONE;

ADULT; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE REGISTRY; FEMALE; FOLLOW UP; GERMANY; HUMAN; HYPERTENSION; HYPOKALEMIA; IDIOPATHIC DISEASE; MALE; MEDICAL RECORD REVIEW; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REMISSION;

ADULT; AGED; AGED, 80 AND OVER; ALDOSTERONE ANTAGONISTS; FEMALE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; RECEPTORS, MINERALOCORTICOID; REMISSION, SPONTANEOUS; RETROSPECTIVE STUDIES; SPIRONOLACTONE;

EID: 84857838812     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04243.x     Document Type: Article

References (30)

1. Mulatero, P., Stowasser, M., Loh, K.C. et al. (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. Journal of Clinical Endocrinology and Metabolism, 89, 1045-1050. (Pubitemid 38368386)
2. Plouin, P.F., Amar, L. & Chatellier, G. (2004) Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. Nephrology, Dialysis, Transplantation, 19, 774-777. (Pubitemid 38455644)
3. Rossi, G.P., Bernini, G., Caliumi, C. et al. (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. Journal of the American College of Cardiology, 48, 2293-2300. (Pubitemid 44873058)
4. Calhoun, D.A., Nishizaka, M.K., Zaman, M.A. et al. (2002) Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension, 40, 892-896. (Pubitemid 35434912)
5. Douma, S., Petidis, K., Doumas, M. et al. (2008) Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet, 371, 1921-1926. (Pubitemid 351778191)
6. Funder, J.W., Carey, R.M., Fardella, C. et al. (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 93, 3266-3281.
7. Karagiannis, A., Tziomalos, K., Papageorgiou, A. et al. (2008) Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opinion on Pharmacotherapy, 9, 509-515. (Pubitemid 351425379)
8. Armanini, D., Fiore, C. & Pellati, D. (2007) Spontaneous resolution of idiopathic aldosteronism after long-term treatment with potassium canrenoate. Hypertension, 50, e69-e70. (Pubitemid 47442748)
9. Armanini, D., Scaroni, C., Mattarello, M.J. et al. (2005) Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate. Journal of Endocrinological Investigation, 28, 236-240. (Pubitemid 43162771)
10. Schirpenbach, C., Segmiller, F., Diederich, S. et al. (2009) The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry. Deutsches Ärzteblatt International, 106, 305-311.
11. Fischer, E., Beuschlein, F., Bidlingmaier, M. et al. (2011) Commentary on the Endocrine Society Practice Guidelines: consequences of adjustment of antihypertensive medication in screening of primary aldosteronism. Reviews in Endocrine & Metabolic Disorders, 12, 43-48.
12. Sukor, N., Gordon, R.D., Ku, Y.K. et al. (2009) Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. Journal of Clinical Endocrinology and Metabolism, 94, 2437-2445.
13. Gordon, R.D., Stowasser, M., Klemm, S.A. et al. (1995) Primary aldosteronism - some genetic, morphological, and biochemical aspects of subtypes. Steroids, 60, 35-41.
14. Armanini, D. & Fiore, C. (2009) Some considerations about evolution of idiopathic primary aldosteronism. Journal of Endocrinological Investigation, 32, 623-625.
15. Lasaridis, A.N., Tourkantonis, A., Spanos, P. et al. (1984) The effects of canrenoate K on corticosteroid biosynthesis in nephrectomized dogs. Journal of Steroid Biochemistry, 20, 923-929.
16. Sundsfjord, J.A., Marton, P., Jorgensen, H. et al. (1974) Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case. Journal of Clinical Endocrinology and Metabolism, 39, 734-739.
17. Conn, J.W. & Hinerman, D.L. (1977) Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies. Metabolism, 26, 1293-1307. (Pubitemid 8243284)
18. Cohn, D., Jackson, R.V. & Gordon, R.D. (1983) Factors affecting the frequency of occurrence of spironolactone bodies in aldosteronomas and non-tumorous cortex. Pathology, 15, 273-277. (Pubitemid 13029292)
19. Born-Frontsberg, E., Reincke, M., Rump, L.C. et al. (2009) Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. Journal of Clinical Endocrinology and Metabolism, 94, 1125-1130.
20. Hannemann, A., Friedrich, N., Ludemann, J. et al. (2010) Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based Study of Health in Pomerania (SHIP-1). Hormone and Metabolic Research, 42, 392-399.
21. Choi, M., Scholl, U.I., Yue, P. et al. (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science, 331, 768-772.
22. Lifton, R.P., Dluhy, R.G., Powers, M. et al. (1992) A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature, 355, 262-265.
23. Jeske, Y.W., So, A., Kelemen, L. et al. (2008) Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II. Clinical and Experimental Pharmacology and Physiology, 35, 380-385. (Pubitemid 351337333)
24. Luft, F. (2010) The renin, angiotensin, aldosterone, and obesity connection. Journal of Molecular Medicine, 88, 861-864.
25. Yvan-Charvet, L. & Quignard-Boulange, A. (2011) Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney International, 79, 162-168.
26. Nishikawa, T. & Omura, M. (2011) Should primary aldosteronism be diagnosed among normotensive subjects during general health check-up and/or at general outpatient clinics? Hypertension Research, 34, 47-48.
27. Snow, M.H., Nicol, P., Wilkinson, R. et al. (1976) Normotensive primary aldosteronism. British Medical Journal, 1, 1125-1126.
28. Shiroto, H., Ando, H., Ebitani, I. et al. (1980) Normotensive primary aldosteronism. American Journal of Medicine, 69, 603-606. (Pubitemid 10018716)
29. Kono, T., Ikeda, F., Oseko, F. et al. (1981) Normotensive primary aldosteronism: report of a case. Journal of Clinical Endocrinology and Metabolism, 52, 1009-1013. (Pubitemid 13237493)
30. Reincke, M., Rump, L.C., Quinkler, M. et al. (2009) Risk factors associated with a low glomerular filtration rate in primary aldosteronism. Journal of Clinical Endocrinology and Metabolism, 94, 869-875.